Literature DB >> 10697742

Occurrence and antibiotic sensitivity of Enterobacteriaceae isolated from a group of Jordanian patients with community acquired urinary tract infections.

Q Abu Shaqra1.   

Abstract

The type and antibiotic sensitivity of urinary tract pathogens may differ in various communities. Of 207 isolates recovered from midstream urine specimens collected from a group of patients with community acquired urinary tract infections (UTI), 86% were species of Enterobacteriaceae. The most frequently recovered pathogens were Escherichia coli (82%), Klebsiella spp. (7.3%), Proteus spp. (6.2%), Enterobacter spp. (3.4%) and Citrobacter spp. (1.1%). High rates of resistance were found against ampicillin (95%), tetracycline (86%), carbenicillin (84%), trimethoprim/sulphamethoxazole (48%), and amoxycillin/clavulanic acid (45%). For the antibiotics tobramycin, aztreonam, ceftriaxone and gentamicin 7% of the isolates were resistant, while resistance varied from 9-18% for amikacin, ciprofloxacin, norfloxacin, nalidixic acid and cefuroxime. The incidence of UTI caused by Enterobacteriaceae was three times higher in females than in males, particularly in young and middle age groups (< or = 19 and 20-39 years).

Entities:  

Mesh:

Year:  2000        PMID: 10697742

Source DB:  PubMed          Journal:  Cytobios        ISSN: 0011-4529


  3 in total

1.  Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Gaza Strip, Palestine.

Authors:  Zakaria El Astal
Journal:  J Biomed Biotechnol       Date:  2005

2.  Urinary tract infection among intellectual disability individuals "etiology and antibiotic resistance patterns" in rehabilitation centers of Mazandaran province, Northern Iran.

Authors:  M Nasrolahei; M Poorhagibagher; M Vahedi; I Maleki
Journal:  J Prev Med Hyg       Date:  2013-09

3.  Dispensing of non-prescribed antibiotics in Jordan.

Authors:  Ammar Almaaytah; Tareq L Mukattash; Julia Hajaj
Journal:  Patient Prefer Adherence       Date:  2015-09-30       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.